Longitudinal evaluation of quality of life (QoL) in patients (Pts) with FGFR2-driven cholangiocarcinoma (CCA) treated with pemigatinib Meeting Abstract
| Authors: | Valle, J. W.; Bibeau, K.; Cho, Y.; Ren, H.; Feliz, L.; Lihou, C. F.; Abou-Alfa, G. K. |
| Abstract Title: | Longitudinal evaluation of quality of life (QoL) in patients (Pts) with FGFR2-driven cholangiocarcinoma (CCA) treated with pemigatinib |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800293 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.276 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 276 -- Source: Wos |
